United States Gastric Cancer Drugs Market Report 2016

Publisher Name :
Date: 15-Sep-2016
No. of pages: 116
Inquire Before Buying

Notes:

Sales, means the sales volume of Gastric Cancer Drugs

Revenue, means the sales value of Gastric Cancer Drugs

This report studies sales (consumption) of Gastric Cancer Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Hoffmann-La Roche

- Eli-lilly

- Sanofi

- Otsuka Holdings

- Novartis

- Amgen

- Boston Biomedical

- AROG Pharmaceuticals

- ARIAD Pharmaceuticals

- Roche

- Merck

- Eli Lilly

- AB Science

- Bayer HealthCare

- Boehringer Ingelheim

- Bristol-Myers Squibb

- Five Prime

- BIND Therapeutics

- Ipsen Biopharmaceuticals

- Eddingpharm

Split by product Types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Gastric Cancer Drugs in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Gastric Cancer Drugs Market Report 2016

Table of Contents
United States Gastric Cancer Drugs Market Report 2016
1 Gastric Cancer Drugs Overview
1.1 Product Overview and Scope of Gastric Cancer Drugs
1.2 Classification of Gastric Cancer Drugs
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Gastric Cancer Drugs
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Gastric Cancer Drugs (2011-2021)
1.4.1 United States Gastric Cancer Drugs Sales and Growth Rate (2011-2021)
1.4.2 United States Gastric Cancer Drugs Revenue and Growth Rate (2011-2021)
2 United States Gastric Cancer Drugs Competition by Manufacturers
2.1 United States Gastric Cancer Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Gastric Cancer Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Gastric Cancer Drugs Average Price by Manufactures (2015 and 2016)
2.4 Gastric Cancer Drugs Market Competitive Situation and Trends
2.4.1 Gastric Cancer Drugs Market Concentration Rate
2.4.2 Gastric Cancer Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Gastric Cancer Drugs Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Gastric Cancer Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Gastric Cancer Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Gastric Cancer Drugs Price by Type (2011-2016)
3.4 United States Gastric Cancer Drugs Sales Growth Rate by Type (2011-2016)
4 United States Gastric Cancer Drugs Sales (Volume) by Application (2011-2016)
4.1 United States Gastric Cancer Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Gastric Cancer Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Gastric Cancer Drugs Manufacturers Profiles/Analysis
5.1 Hoffmann-La Roche
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Gastric Cancer Drugs Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Hoffmann-La Roche Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Eli-lilly
5.2.2 Gastric Cancer Drugs Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Eli-lilly Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Sanofi
5.3.2 Gastric Cancer Drugs Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Sanofi Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Otsuka Holdings
5.4.2 Gastric Cancer Drugs Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Otsuka Holdings Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Novartis
5.5.2 Gastric Cancer Drugs Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Novartis Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Amgen
5.6.2 Gastric Cancer Drugs Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Amgen Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Boston Biomedical
5.7.2 Gastric Cancer Drugs Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Boston Biomedical Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 AROG Pharmaceuticals
5.8.2 Gastric Cancer Drugs Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 AROG Pharmaceuticals Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 ARIAD Pharmaceuticals
5.9.2 Gastric Cancer Drugs Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 ARIAD Pharmaceuticals Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Roche
5.10.2 Gastric Cancer Drugs Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Roche Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Merck
5.12 Eli Lilly
5.13 AB Science
5.14 Bayer HealthCare
5.15 Boehringer Ingelheim
5.16 Bristol-Myers Squibb
5.17 Five Prime
5.18 BIND Therapeutics
5.19 Ipsen Biopharmaceuticals
5.20 Eddingpharm
6 Gastric Cancer Drugs Manufacturing Cost Analysis
6.1 Gastric Cancer Drugs Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Gastric Cancer Drugs
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Gastric Cancer Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Gastric Cancer Drugs Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Gastric Cancer Drugs Market Forecast (2016-2021)
10.1 United States Gastric Cancer Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Gastric Cancer Drugs Sales Forecast by Type (2016-2021)
10.3 United States Gastric Cancer Drugs Sales Forecast by Application (2016-2021)
10.4 Gastric Cancer Drugs Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Gastric Cancer Drugs
Table Classification of Gastric Cancer Drugs
Figure United States Sales Market Share of Gastric Cancer Drugs by Type in 2015
Table Application of Gastric Cancer Drugs
Figure United States Sales Market Share of Gastric Cancer Drugs by Application in 2015
Figure United States Gastric Cancer Drugs Sales and Growth Rate (2011-2021)
Figure United States Gastric Cancer Drugs Revenue and Growth Rate (2011-2021)
Table United States Gastric Cancer Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Gastric Cancer Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Gastric Cancer Drugs Sales Share by Manufacturers
Figure 2016 Gastric Cancer Drugs Sales Share by Manufacturers
Table United States Gastric Cancer Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Gastric Cancer Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Gastric Cancer Drugs Revenue Share by Manufacturers
Table 2016 United States Gastric Cancer Drugs Revenue Share by Manufacturers
Table United States Market Gastric Cancer Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Gastric Cancer Drugs Average Price of Key Manufacturers in 2015
Figure Gastric Cancer Drugs Market Share of Top 3 Manufacturers
Figure Gastric Cancer Drugs Market Share of Top 5 Manufacturers
Table United States Gastric Cancer Drugs Sales by Type (2011-2016)
Table United States Gastric Cancer Drugs Sales Share by Type (2011-2016)
Figure United States Gastric Cancer Drugs Sales Market Share by Type in 2015
Table United States Gastric Cancer Drugs Revenue and Market Share by Type (2011-2016)
Table United States Gastric Cancer Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Gastric Cancer Drugs by Type (2011-2016)
Table United States Gastric Cancer Drugs Price by Type (2011-2016)
Figure United States Gastric Cancer Drugs Sales Growth Rate by Type (2011-2016)
Table United States Gastric Cancer Drugs Sales by Application (2011-2016)
Table United States Gastric Cancer Drugs Sales Market Share by Application (2011-2016)
Figure United States Gastric Cancer Drugs Sales Market Share by Application in 2015
Table United States Gastric Cancer Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Gastric Cancer Drugs Sales Growth Rate by Application (2011-2016)
Table Hoffmann-La Roche Basic Information List
Table Hoffmann-La Roche Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Hoffmann-La Roche Gastric Cancer Drugs Sales Market Share (2011-2016)
Table Eli-lilly Basic Information List
Table Eli-lilly Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli-lilly Gastric Cancer Drugs Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Gastric Cancer Drugs Sales Market Share (2011-2016)
Table Otsuka Holdings Basic Information List
Table Otsuka Holdings Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Otsuka Holdings Gastric Cancer Drugs Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Gastric Cancer Drugs Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Gastric Cancer Drugs Sales Market Share (2011-2016)
Table Boston Biomedical Basic Information List
Table Boston Biomedical Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boston Biomedical Gastric Cancer Drugs Sales Market Share (2011-2016)
Table AROG Pharmaceuticals Basic Information List
Table AROG Pharmaceuticals Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table AROG Pharmaceuticals Gastric Cancer Drugs Sales Market Share (2011-2016)
Table ARIAD Pharmaceuticals Basic Information List
Table ARIAD Pharmaceuticals Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table ARIAD Pharmaceuticals Gastric Cancer Drugs Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Gastric Cancer Drugs Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Gastric Cancer Drugs Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Gastric Cancer Drugs Sales Market Share (2011-2016)
Table AB Science Basic Information List
Table AB Science Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table AB Science Gastric Cancer Drugs Sales Market Share (2011-2016)
Table Bayer HealthCare Basic Information List
Table Bayer HealthCare Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer HealthCare Gastric Cancer Drugs Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Gastric Cancer Drugs Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Gastric Cancer Drugs Sales Market Share (2011-2016)
Table Five Prime Basic Information List
Table Five Prime Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Five Prime Gastric Cancer Drugs Sales Market Share (2011-2016)
Table BIND Therapeutics Basic Information List
Table BIND Therapeutics Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table BIND Therapeutics Gastric Cancer Drugs Sales Market Share (2011-2016)
Table Ipsen Biopharmaceuticals Basic Information List
Table Ipsen Biopharmaceuticals Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ipsen Biopharmaceuticals Gastric Cancer Drugs Sales Market Share (2011-2016)
Table Eddingpharm Basic Information List
Table Eddingpharm Gastric Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eddingpharm Gastric Cancer Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastric Cancer Drugs
Figure Manufacturing Process Analysis of Gastric Cancer Drugs
Figure Gastric Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Gastric Cancer Drugs Major Manufacturers in 2015
Table Major Buyers of Gastric Cancer Drugs
Table Distributors/Traders List
Figure United States Gastric Cancer Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Gastric Cancer Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Gastric Cancer Drugs Production Forecast by Type (2016-2021)
Table United States Gastric Cancer Drugs Consumption Forecast by Application (2016-2021)
  • Global Aurora Kinase B Market Research Report 2017
    Published: 20-Nov-2017        Price: US 2900 Onwards        Pages: 103
    In this report, the global Aurora Kinase B market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Aurora Kinase B in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Jap......
  • Global Human Growth Hormone Market Research Report 2017
    Published: 20-Nov-2017        Price: US 2900 Onwards        Pages: 115
    In this report, the global Human Growth Hormone market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Human Growth Hormone in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China......
  • Global POC Molecular Diagnostics Market Size, Status and Forecast 2022
    Published: 20-Nov-2017        Price: US 3300 Onwards        Pages: 108
    This report studies the global POC Molecular Diagnostics market, analyzes and researches the POC Molecular Diagnostics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Abbott - bioMerieux - Danaher - BD - Certest Biotec - F. Hoffmann-La Roche - NeoGenomics - Bionano Genomics - ExcitePCR - Micronics - Nimagen......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Liquid Lenses Market 2017 Forecast to 2022
    Published: 20-Nov-2017        Price: US 4880 Onwards        Pages: 116
    A liquid lens uses one or more fluids to create an infinitely-variable lens without any moving parts by controlling the meniscus (the surface of the liquid.) There are two primary types, Electrowetting-Based Liquid Lense and Liquid Crystal Lense. These are not to be confused with liquid-formed lenses that are created by placing a drop of plastic or epoxy on a surface, which is then allowed to harden into a lens shape. Scope of the Report: This report focuses on the Liquid L......
  • Global OTC Drug Market Research Report 2017
    Published: 20-Nov-2017        Price: US 2900 Onwards        Pages: 113
    In this report, the global OTC Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of OTC Drug in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan - So......
  • Global Vinorelbine Market Research Report 2017
    Published: 20-Nov-2017        Price: US 2900 Onwards        Pages: 115
    In this report, the global Vinorelbine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Vinorelbine in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan......
  • Global Neuroleptic Market Research Report 2017
    Published: 20-Nov-2017        Price: US 2900 Onwards        Pages: 100
    In this report, the global Neuroleptic market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Neuroleptic in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan......
  • Global Dengue Virus Diagnostic Tests Market Research Report 2017
    Published: 17-Nov-2017        Price: US 2900 Onwards        Pages: 121
    In this report, the global Dengue Virus Diagnostic Tests market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Dengue Virus Diagnostic Tests in these regions, from 2012 to 2022 (forecast), covering - North America - Europe......
  • Global Cetrimide Market Professional Survey Report 2017
    Published: 17-Nov-2017        Price: US 3500 Onwards        Pages: 105
    This report studies Cetrimide in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Uma Brothers - Argon Drugs - Wellona Pharma - Dishman Group - Green......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs